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ABSTRACT 
 This study was designed to investigate potential anti-diarrhoeal activity of the orally 
administrated water extract of Hydnora abyssinica roots to rats. The potential activity of the 
extract was tested by faecal mass inhibition. Twenty-four albino rats were divided into 5 
groups (a control + 3 test groups + loperamide group) receiving oral doses of 100, 200 and 
400 mg extract/kg body weight/rat, 3 mg loperamide (reference anti-diarrhoeal drug)/kg 
body weight/rat and 1 ml/kg body weight/rat of normal saline (control). All the rats were 
orally given, 30 minutes subsequent to extract administration, an acute diarrhoea inducer (1 
ml castor oil/ kg body weight/rat). The weight of faeces was recorded at 4 and 6 hours for 
assessment of diarrhoeal inhibition. The extract showed a significant (P ≤ 0.05) anti-
diarrhoeal activity against castor oil induced diarrhoea in all rats at the 4
th
 hrs post treatment 
with reduction rates of 46.78%, 63.21% and 74.68% for the doses 100, 200 and 400 mg/kg 
body weight, respectively. The same doses recorded inhibition rates of 27.42%, 50.88% and 
60.13%, respectively, at the 6
th
 hours post treatment. Serum samples were taken at 4 and 24 
hrs and analyzed for enzymatic activities of AST and ALT, metabolic indicators, total 
protein, albumin, sodium, potassium and calcium. Metabolic indicators, total protein, 
albumin, sodium, potassium and calcium showed significant increase while calcium showed 
significant decrease. The antidiarrhoeal effect produced by H. abyssinica can be due to 
inhibition of prostaglandin, the diarrhoeal inducer or due to antimotility and antisecretary 
activity of the plant extract. It is concluded that the results support the claim of traditional 
practioners about the therapeutic values of H. abyssinica for treatment of diarrhoea in 
traditional medicine.    
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INTRODUCTION 
 
Diarrhoea is one of the most serious health problems in both, man and animals. It 
occurs in all age groups‚ especially in the young causing two main dangers, death and 
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malnutrition (WHO‚ 1992). In new born animals‚ despite improvements in management 
practices; prevention and treatment strategies, diarrhoea is one of the most common disease 
complexes. It is a significant cause of economic loss due not only to mortalities‚ but also to 
medical costs and poor growth (Woode and Crouch‚ 1978).  In man, diarrhoea is, also, a 
leading cause of morbidity and mortality especially among children in developing countries 
(Coker et al., 1998), resulting in a loss of about 1.5 million lives each year (WHO, 2004). 
This toll is greater than that caused by AIDS, malaria and measles combined. Therefore, to 
combat the problem of diarrhoea in developing countries, the world health organization 
(WHO) has constituted a diarrhoea disease control (DDC) programme which includes 
studies of traditional medicine practices together with the evaluation of health education and 
prevention approaches (Syder and Merson, 1982). 
          Medicinal herbs constitute an indispensable component of the traditional medicine 
practiced worldwide. Thus, medicinal plants are one of the useful areas of research in this 
regard because the majority of people in the developing countries, despite the emergence of 
a number of drugs and the availability of enormous approaches for diarrheoal management, 
rely on herbal drugs. This is due to their economical viability, accessibility and ancestral 
experiences for management of all sorts of diseases including diarrhoea. The popular 
medicinal plant Hydnora abyssinica, family (Hydronaceae) (Figs. 1, 2, 3) which is known 
locally in Sudan as (Tartous), is grown abundantly in the tropical regions as well as in 
Sudan. The infusion of the roots powder is traditionally used in folkloric medicine for 
various disorders especially in treatment of diarrhoea, dysentery and to stop haemorrhages 
(Hyde and Wursten, 2010). However‚ this therapeutic potentiality has not been evaluated 
and no previous scientific literature was found on its anti-diarrhoeal activity.  Hence, the 
present study was designed to evaluate the anti-diarrhoeal activity of the roots extract of H. 
abyssinica in experimentally-induced diarrhoea model in rats. 
      
    
 Fig 1. Un- opened and Broken flower  of Hydnora abyssinica 
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Fig 2: Hydnora abyssinica A. Braun ex Schweinf 
 
 
Fig 3: Hydnora abyssinica Schweinf. 
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MATERIALS AND METHODS 
 
 The collected Hydnora abyssinica roots were identified and authenticated by a plant 
taxonomist at the Department of Botany, Faculty of Science, University of Khartoum, 
Sudan.  The roots of the plant were shade dried and pulverized using pestle and mortar. A 
weight of 500 g of the coarse powder of the plant material was subjected to successive 
aqueous extract at the Medicinal and Aromatic Plants Research Institute (MAPRI), National 
Center for Research Khartoum, Sudan. It was carried out by soaking into boiling distilled 
water and the mixture was left for 4 hours at room temperature with occasional shaking. The 
filtrates were cooled, concentrated and then freeze dried (Komolafe et al., 1988). The 
extract obtained was a glittery brown- greenish powder. The yield was 14 % (w/w). Twenty 
five Wister albino rats of either sex weighing 100−150 gm were obtained from the MAPRI, 
where they were housed in standard cages and were provided with food and water ad 
libitum. The animals were randomly evenly divided into 5 groups. They were starved for 18 
hours prior to the experiment but were allowed free access to water. 
 The rats were all initially screened by giving each 1.0 ml of castor oil and only those 
showing diarrhoea were selected for further study. Three test doses (100, 200 and 400 
mg/kg Bwt/rat) of plant extract were selected on a trial basis and were orally administrated 
by gavage to the animals of the first three groups. The fourth group (positive control) 
received loperamide (Hikma Pharmaceutical, Amman, Jordan) at 3 mg/kg Bwt/rat as 
reference drug while the fifth group (negative control) received 1 ml/kg Bwt/rat normal 
saline. Thirty minutes after drug treatment, each animal was orally given 1 ml/kg Bwt/rat 
castor oil. The animals were then individually caged over clean filter papers which were 
replaced every hour. Clinical signs and mortality rates were observed for 24 hours. First 
defecation time and frequency of defecation were recorded. Total weight of faecal mass was 
successively collected and weighed at 4 and 6 hours post administration of castor oil. Anti-
diarrhoeal activity was determined in terms of percentage reduction in cumulative faecal 
mass in comparison with the un-treated control group (Patel et al., 2006) by using the 
following equation: 
Inhibition % = 
𝑎−𝑏
𝑎
 X100  
Where (a) is mean of the faeces weight in the control and (b) is mean of the faeces weight in 
the treated rats (Snedecor and Cochran, 1989). 
 
Statistical methods 
          The experimental results were expressed as the means ± standard error of the mean. 
Data were evaluated by one way analysis of variance (ANOVA) and means were compared 
using Duncan’s Multiple Range Test. P≤ 0.05 was considered significant. 
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RESULTS 
 
The extract caused neither death nor any observable clinical toxicity signs in rats 
when administrated orally during the experimental period at the doses used.       The 
aqueous extract of H. abyssinica showed marked dose dependent antidiarrhoeal activity. It 
significantly (P ≤ 0.01) prolonged the time for diarrhoeal induction and reduced both the 
frequency of defecation (data not shown) as well as the weight of faeces in a dose dependant 
manner in rats at all doses (100, 200 and 400 mg/kg) used with highly inhibition 
percentages of 46.78, 63.21 and 74.68% respectively after the first four hours and 27.42, 
50.88 and 60.13% respectively for the same doses at six hours compared to  the control (un-
treated group) (Table 1).   Generally, the highest inhibition percentage obtained was 74.68% 
with the dose 400 mg/kg Bwt of the extract which was comparatively greater than 72.21%, 
the maximum inhibition percentage produced by loperamide (the reference compound).  
 At 4 hours, the values of sodium and potassium in all groups (100, 200 and 400 
mg//kg) showed significant increase (P ≤ 0.05) when compared with the un-treated control 
group. The dose 400 mg/kg showed the same values of the reference compound (Table 2). 
At 24 hrs, the levels of sodium and potassium demonstrated no significant changes in 
concentrations at all groups (Table 3).    In all groups, there was a significant increase (P ≤ 
0.05) in values of RBCs and Hb concentration compared with the control group (Table 4).  
 
Table 1. Effect of H. abyssinica roots aqueous extract on castor oil–induced diarrhoea in 
rats 
Hours Groups Dose  mg/kg Faeces weight mg 
Inhibition
% 
 
 
4hrs 
G1 un-treated control (saline)+ castor 
oil 
01.89± 00.01 a 00.00 
G2  100mg/kg H. aby. + castor oil 01.01 ± 00.00 b 46.78 
G3  200mg/kg H. aby. + castor oil 00.70 ± 00.03 c 63.21 
G4 400mg/kg H. aby.  + castor oil 00.48 ± 00.01 e 74.68 
G5 3mg/kg Loperamide + castor oil 00.63 ± 00.01 d 66.54 
 
 
6hrs 
G1 un-treated control (saline) + castor 
oil 
02.15 ± 00.00 a 00.00 
G2 100mg/kg H. aby.  + castor oil 01.56 ± 00.01 b 27.42 
G3  200mg/kg H. aby. +  castor oil 01.06 ± 00.02 c 50.88 
G4  400mg/kg H. aby. + castor oil 00.87 ± 00.03 d 60.13 
G5 3mg/kg Loperamide + castor oil 00.60 ± 00.00 e 72.21 
Means ± SE in the same column with the same letter are not significantly different at  0.05 
level.  H. aby. = Hydnora abyssinica 
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               Table 2. Values of serum metabolites of orally treated rats with H. abyssinica 
                               roots aqueous extract at 4 hours 
Groups/dose 
Total Protein  
g/dl 
Albumin  
g/dl 
Sodium  
mg/dl 
Potassium 
mg/dl 
Calcium  
mg/dl 
G1 un-treated control (saline) + castor oil 02.24 ± 00.17c 01.76 ± 00.21 b 106.30 ± 01.93c 00.98 ± 00.07 c 14.18 ± 00.20 b 
 G2 100mg/kg H. abyssinica      +  castor oil 02.70 ± 00.12c 02.00 ±00.18ab 116.50 ±01.42b 01.24 ±00.09ab 14.10 ± 00.15bc 
 G3 200mg/kg H. abyssinica +  castor oil 03.22 ± 00.15b 02.26 ±00.07ab 117.78 ±01.42b   01.44 ±00.15ab 14.06 ±00.16 bc 
G4 400mg/kg H. abyssinica  + castor oil 04.52 ± 00.16a 02.50 ± 00.17 a 139.26 ±00.67a 01.74 ± 00.12 a 13.64 ± 00.10 c 
G5 3mg/kg loperamide + castor  oil 04.32 ± 00.19a 02.50 ± 00.15 a 137.30 ±00.46a 01.78 ± 00.11 a 12.76 ± 00.21 d 
         Means ± SE in the same column with the same letter are not significantly different at 5% level. 
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Table 3. Values of serum metabolites of treated rats with H. abyssinica aqueous extract at 24 hours. 
Groups/dose 
Total protein  
g/dl 
Albumin 
 g/dl 
Sodium 
 mg/dl 
Potassium mg/dl 
Calcium  
mg/dl 
G1 un-treated control (saline) + castor oil 04.96 ± 00.27 b 03.46 ± 00.22 a 134.80 ± 02.07 ab 05.28 ± 00.19 b 11.56 ± 00.13 c 
 G2 100mg/kg H. abyssinica  + castor oil 06.00 ± 00.19 a 03.10 ± 00.10 ab 135.50 ± 01.65 a 05.68 ± 00.21 ab 12.46 ± 00.18 b 
 G3 200mg/kg H. abyssinica  + castor oil 06.16 ± 00.25 a 03.18 ± 00.14 ab 131.76 ± 00.99 b 05.80 ± 00.30 ab 12.40 ± 00.16 b 
G4 400mg/kg H. abyssinica  + castor oil 05.98 ± 00.16 a 03.00 ± 00.15 ab 135.00 ± 00.91 ab 06.00 ± 00.22 ab 13.60 ± 00.19 a 
G5 3mg/kg loperamide + castor  oil 06.58 ± 00.17 a 03.30 ± 00.14 a 132.26 ± 00.81 ab 05.70 ± 00.20 ab 12.68 ± 00.14 b 
         Means ± SE in the same column with the same letter are not significantly different at 5% level. 
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   Table 4. Haematological values of rats treated with H. abyssinica aqueous extract at 24 hours. 
Groups/dose RBCS.10
6
/mm
3
 Hb (g/dl) PCV% MCV(fl) MCHC% 
G1 un-treated control (saline) + castor oil 05.21 ± 00.17 b 10.48 ± 00.19b 39.54 ± 00.28 a 64.06 ± 00.26 ab 35.54 ± 00.22 a 
 G2 100mg/kg H. abyssinica   +  castor oil 05.49 ± 00.10 a 11.52 ± 00.15 a 37.16 ± 00.61 b 62.96 ± 01.35 b 33.88 ± 00.26 b 
 G3 200mg/kg H. abyssinica + castor oil 05.52 ± 00.19 a 11.58 ± 00.29 a 33.76 ± 00.50 c 63.24 ± 00.39 b 34.30 ± 00.34 b 
G4 400mg/kg H. abyssinica + castor oil 05.43 ± 00.18 a 12.08 ± 00.18 a 32.08 ± 00.16 d 65.38 ± 00.47 a 33.50 ± 00.33 b 
G5 3mg/kg loperamide +castor  oil 05.56 ± 00.16 a 11.92 ± 00.97 a 33.70 ± 00.31 c 63.82 ± 00.94 b 33.64 ± 00.19 b 
         Means ± SE in the same column with the same letter are significantly different at 5% level. 
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DISCUSSION 
 
 The inhibition of experimental diarrhoea and the reduction in faecal output by a 
substance are the basis of the pharmacological evaluation of a potential antidiarrhoeal 
agent.  Castor oil is an effective laxative as it decreases fluid absorptions, increases 
secretion in the small intestine and colon, and affects smooth muscle contractility in the 
intestine. It is well known that castor oil produces secretory and motility diarrhoea due to 
its active component recinolic acid (Gaginella and Bass, 1978; Donowitz and Welsh, 
1987; Capasso et al., 1994). Several mechanisms have been supposed to be involved in 
the diarrhoeal effect of castor oil (Izzo, 1996). These include inhibition of intestinal Na
+
 , 
K
+ 
-ATPase activity to reduce normal fluid absorption (Phillips et al., 1965; Gaginella 
and Bass, 1978; Nell and Rummel, 1984), activation of adenylate cyclase or mucosal 
cAMP- mediated active secretion (Gaginella et al., 1978; Capasso et al., 1994) and 
stimulation of prostaglandin formation (Beubler and Juan, 1979;  Capasso et al., 1986; 
Galvez et al., 1993) and platelet-activating factor (Capasso et al., 1992; Pinto et al 1992; 
Mascolo et al., 1996). Most recently nitric oxide has been claimed to contribute to the 
diarrhoeal effect of castor oil (Mascolo et al., 1996). Despite the fact that numerous 
mechanisms have been proposed for the diarrhoeal effect of castor oil, it has not been 
possible to define the correct mechanisms of action (Mascolo et al., 1994). 
Prostaglandins contribute to the pathophysiological functions in the gastrointestinal tract 
(Sanders, 1984). Inhibition of prostaglandin biosynthesis delayed castor oil induced 
diarrhoea (Awouters et al., 1978, Bruton, 1985) since the effect of castor oil is associated 
with prostaglandin release (Besra et al., 2002). Loperamide, which is at present one of the 
most efficacious and widely employed antidiarrhoeal drug, was used in this study as a 
standard antidiarrhoeal compound. Loperamide effectively antagonized the diarrhoea 
induced by castor oil (Neimegeer et al., 1974), prostaglandin (Karim and Adaikan, 1997) 
or cholera toxin (Farack et al., 1981). The therapeutic effect of the Loperamide is 
believed to be due to its antimotility and antisecretory activity (Couper, 1987).  
The aqueous extract of H. abyssinica roots against castor oil induced diarrhoea in 
rats showed significant reduction and highly inhibition percentage in weight of faeces at 
all doses used (100, 200 and 400 mg/kg Bwt/rat) and this inhibition was accompanied by 
a dose dependent manner. An interesting observation in this extract was that the 
minimum dose (100 mg/kg) of the extract was able to inhibit castor oil-induced diarrhoea 
from the earliest hours and this may be due to sufficient absorption of the extract besides 
the potent antidiarrhoeal ingredients the extract contains. In addition, the maximum dose 
of the extract (400 mg/kg) showed almost similar anti-diarrhoeal activity as that of 
Loperamide (3 mg/kg) after 6 hours and even better than the reference compound 
Loperamide at 4 hours.  
It is well established that some plant constituents can significantly inhibit the 
biosynthetic pathway of several released mediators such as prostaglandins (Speroni et al., 
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2005). Based on these observations, it seems that the anti-diarrhoeal effect of H. 
abyssinica aqueous extract may be due to the inhibition of prostaglandin biosynthesis but 
needs further analysis to prove this claim. The inhibitory effect of the plant extract 
justified the use of the plant as a non-specific antidiarrhoeal agent in folkloric medicine. 
It is concluded that the aqueous extract of H. abyssinica roots possesses a significant 
antidiarrhoeal activity verified by the highly percentage of inhibition on weight of the 
faeces. These findings provide a scientific support for the traditional use of the plant in 
treating diarrhoea. However, further phytochemical and pharmacological studies are 
required to identify the active ingredient(s) and exact mechanism(s) of action.  
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